| Literature DB >> 29914550 |
Alexandre Gomes Vizzoni1, Margareth Catoia Varela1, Luiz Henrique Conde Sangenis1, Alejandro Marcel Hasslocher-Moreno1, Pedro Emmanuel Alvarenga Americano do Brasil1, Roberto Magalhães Saraiva2.
Abstract
BACKGROUND: Chagas disease control programmes have decreased the prevalence of Chagas disease in Latin America. Together with migration to urban areas and increase in life expectancy, a new scenario for Chagas disease has emerged in Brazil with most patients currently elderly individuals living in urban areas. However, acute Chagas disease cases still occur due to vector transmission by sylvatic vectors and oral transmission by contaminated food. Therefore, we characterized the clinical and epidemiological profile of the patients followed at Evandro Chagas National Institute of Infectious Diseases in Rio de Janeiro, Brazil. We aimed to identify the clinical forms, associated co-morbidities, and geographical areas where younger patients originate from. This will aid in the identification of potential challenges to be currently faced.Entities:
Keywords: Chagas disease; Elderly patients; Geoprocessing; Neglected tropical disease; Trypanosoma cruzi
Mesh:
Year: 2018 PMID: 29914550 PMCID: PMC6006711 DOI: 10.1186/s13071-018-2929-y
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Distribution of socio-demographic characteristics in the studied groups
| Variable | Clinical form | |||||
|---|---|---|---|---|---|---|
| Indeterminate ( | Cardiac ( | Digestive ( | Mixed ( | Total ( |
| |
| Sex | 0.194 | |||||
| Male | 76 (42.2) | 156 (45.5) | 9 (26.5) | 26 (41.9) | 267 (43.1) | – |
| Female | 104 (57.8) | 187 (54.5) | 25 (73.5) | 36 (58.1) | 352 (56.9) | |
| Age, years | 55.5 ± 12.7 | 61.5 ± 11.3 | 61.6 ± 13.9 | 65.2 ± 9.6 | 60.1 ± 12.1 | < 0.001 |
| Ethnicity | 0.926 | |||||
| Caucasian | 73 (40.5) | 142 (41.4) | 16 (47.1) | 23 (36.5) | 254 (41.0) | – |
| Afro-Brazilian | 25 (13.9) | 46 (13.4) | 6 (17.6) | 10 (15.9) | 87 (14.1) | |
| Mixed/Pardo | 82 (45.6) | 155 (45.2) | 12 (35.3) | 29 (46.8) | 278 (44.9) | |
| Place of origin | 0.192 | |||||
| North | – | 1 (0.3) | – | – | 1 (0.2) | – |
| Northeast | 118 (65.6) | 243 (70.8) | 24 (70.6) | 40 (64.6) | 425 (68.6) | |
| South | 8 (4.4) | 1 (0.3) | – | 2 (3.2) | 11 (1.8) | |
| Southeast | 52 (28.9) | 91 (26.6) | 10 (29.4) | 19 (30.6) | 172 (27.8) | |
| Central-West | 2 (1.1) | 7 (2.0) | – | 1 (1.6) | 10 (1.6) | |
| Time outside the endemic area | ||||||
| < 10 years | 24 (13.8) | 25 (7.5) | 2 (6.1) | – | 51 (8.5) | 0.002 |
| 10–20 years | 53 (30.5) | 73 (22.0) | 6 (18.2) | 21 (35) | 153 (25.5) | – |
| > 20 years | 90 (51.7) | 227 (68.4) | 25 (75.7) | 37 (61.7) | 379 (63.3) | |
| Born in RJ state | 7 (4.0) | 7 (2.1) | – | 2 (3.3) | 16 (2.7) | |
Fig. 1Place of origin of the patients with Chagas disease who constitute the INI cohort
Distribution of patient frequencies by age group in the different states
| State | Age group | |||
|---|---|---|---|---|
| 18–44 years | 45–64 years | ≥65 years | Total | |
| Alagoas | 5 (6.8) | 28 (9.1) | 15 (6.3) | 48 (7.8) |
| Bahia | 7 (9.5) | 72 (23.3) | 71 (30.1) | 150 (24.2) |
| Ceará | 27 (36.5) | 31 (10.0) | 8 (3.9) | 66 (10.7) |
| Espírito Santo | 2 (2.7) | 1 (0.3) | 1 (0.4) | 4 (0.6) |
| Goiás | – | 7 (2.3) | 1 (0.4) | 8 (1.2) |
| Maranhão | – | 3 (1.0) | – | 3 (0.5) |
| Minas Gerais | 6 (8.1) | 65 (21.0) | 59 (25.0) | 130 (21.0) |
| Mato Grosso do Sul | – | 1 (0.3) | 1 (0.4) | 2 (0.3) |
| Pará | – | 1 (0.3) | – | 1 (0.2) |
| Paraíba | 14 (18.9) | 40 (13.0) | 24 (10.2) | 78 (12.6) |
| Pernambuco | 3 (4.0) | 21 (6.8) | 37 (15.6) | 61 (9.9) |
| Piauí | – | 7 (2.3) | 2 (0.8) | 9 (1.5) |
| Paraná | – | 6 (2.0) | – | 6 (1.0) |
| Rio de Janeiro | 9 (12.2) | 13 (4.2) | 6 (2.5) | 28 (4.5) |
| Rio Grande do Norte | – | 5 (1.6) | 1 (0.4) | 6 (1.0) |
| Rio Grande do Sul | 1 (1.3) | 2 (0.6) | 2 (0.8) | 5 (0.8) |
| Sergipe | 4 (1.3) | 4 (1.6) | 8 (1.2) | |
| São Paulo | 2 (0.6) | 4 (1.6) | 6 (1.0) | |
Fig. 2Spatial distribution of INI cohort Chagas disease patients stratified by age group (a 18–44 years-old, b 45–64 years-old, c ≥ 65 years-old)
Comorbidities frequencies according to Chagas disease clinical form
| Comorbidities | Clinical form | |||
|---|---|---|---|---|
| Indeterminate ( | Cardiac ( | Digestive ( | Mixed ( | |
| SAH | 100 (55.5) | 193 (56.2) | 18 (52.9) | 36 (58.0) |
| Dyslipidemia | 84 (46.6) | 137 (39.9) | 12 (35.2) | 28 (45.1) |
| Diabetes mellitus | 53 (29.4) | 112 (32.6) | 5 (14.7) | 15 (24.1) |
Abbreviation: SAH systemic arterial hypertension
Comorbidities frequencies according to age groups
| Comorbidities | Age groups | |||
|---|---|---|---|---|
| 18–44 ( | 45–64 ( | ≥ 65 ( | ||
| SAH | 6 (7.6) | 178 (57.6) | 163 (69.1) | < 0.001 |
| Dyslipidemia | 14 (17.7) | 138 (44.7) | 109 (46.2) | < 0.001 |
| Diabetes mellitus | 6 (7.6) | 93 (30.1) | 86 (36.4) | < 0.001 |
Abbreviations: SAH systemic arterial hypertension
LVEF in patients with indeterminate and cardiac form of Chagas disease
| Stage |
| Mean | SD | ||
|---|---|---|---|---|---|
| LVEF (%) | Indeterminate | 164 | 70.6 | 6.4 | |
| A | 112 | 69.2 | 7.5 | ||
| B1 | 107 | 56.4 | 9.6*† | < 0.001 | |
| B2 | 18 | 39.6 | 5.4*†‡ | ||
| C | 78 | 31.2 | 9.9*†‡ | ||
| D | 18 | 29.9 | 10.6*†‡#ǁ |
aOne-way ANOVA Bonferroni post-hoc
*P < 0.05 vs indeterminate; †P < 0.05 vs stage A; ‡P < 0.05 vs stage B1; #P < 0.05 vs stage B2; ǁP < 0.05 vs stage C